Peptide Atlas · Mineral

Magnesium chloride hexahydrate

In a randomized trial in 130 patients after coronary artery bypass surgery, a 48-hour intravenous infusion of 50 mmol magnesium chloride reduced supraventricular arrhythmias from 37.5% on placebo to 16.7%.

emerging

provisional
PubChem 24644
1 citation
0 discussions
0 followers
MgCl2·6H2O

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 1 citation resolves to their original source. · 0 posts naming it, 0 members counted once each.

Evidence, kept apart

The Atlas never mixes evidence types into one blob. Each claim below carries the tier it actually sits in; an unresolved citation is shown and does not move the page.

Evidence map for Magnesium chloride hexahydrate. Tier reflects study design, not enthusiasm.
Claim	Tier	Source
Intravenous magnesium chloride reduced supraventricular arrhythmias after coronary surgery (RCT, n=130)	emerging	pmid 8267992

Unanswered questions

No open questions on file. Either everything about this molecule is known, or nobody has admitted what is not.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.